Building a Robust Clinical Pharmacology & Model-Informed Drug Development Strategy for New Alzheimer’s Disease Drugs Blog Building a Robust Clinical Pharmacology & Model-Informed Drug Development Strategy for New Alzheimer’s Disease Drugs Alzheimer's disease (AD) is one of the most common forms of neurodegenerative dementia in the…CertaraSeptember 20, 2021
What does the Clinical Pharmacology Plan for a Biologic Look Like? On-Demand Webinar What does the Clinical Pharmacology Plan for a Biologic Look Like? Monoclonal antibodies are now widely used in the treatment of several diseases, providing effective and…CertaraAugust 6, 2021
Key Considerations to Ensure Maximal Probability of Antibody Drug Conjugate Development Success Blog Key Considerations to Ensure Maximal Probability of Antibody Drug Conjugate Development Success Antibody drug conjugates (ADC) are a unique way to obliterate tumor cells and represent an…CertaraJuly 8, 2021
8 Tips for Successfully Developing Oligonucleotide Therapies Blog 8 Tips for Successfully Developing Oligonucleotide Therapies By Eva Gil Berglund and Nathalie H Gosselin Oligonucleotide therapeutics are a validated class of…CertaraFebruary 1, 2021
“Where do I start?”: Strategies for selecting the first dose for human clinical trials White Paper “Where do I start?”: Strategies for selecting the first dose for human clinical trials This guide to dose selection for first-in-human studies explains the conceptual framework, methods, and tools…CertaraDecember 22, 2020
Clinical Pharmacology Gap Analysis: Lessons Learned Blog Clinical Pharmacology Gap Analysis: Lessons Learned Clinical pharmacology gap analysis is a tool for outlining your drug program’s needs, prioritizing these…CertaraAugust 10, 2018
Metformin Treatment of Type 2 Diabetes Mellitus in Pregnancy: Update on Safety and Efficacy Publication Metformin Treatment of Type 2 Diabetes Mellitus in Pregnancy: Update on Safety and Efficacy CertaraApril 25, 2018
Using M&S to Evaluate Oncology Drug Dosing Blog Using M&S to Evaluate Oncology Drug Dosing There are numerous challenges in developing oncology drugs: (1) they are often very toxic which…CertaraApril 13, 2018
Using a Pharmacology to Payer Framework to Support Product Development Blog Using a Pharmacology to Payer Framework to Support Product Development Modeling and simulation (M&S) of complex systems has primarily advanced vertically in differing scientific domains…CertaraMarch 16, 2018
Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics Publication Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics CertaraMarch 1, 2018